We noticed that despite that Dasatinib was able to consistently inhibit p‐Lyn in human HCC cell lines, Dasatinib at the dose we were using, did not lead to significant decreased p‐Lyn expression in c‐Myc mouse HCC samples. This evidence concerns the gene LYN and hepatocellular carcinoma.